Brainomix earns new FDA nod for stroke imaging tech
April 8, 2025
Brainomix announced today that it received FDA clearance for a new feature within its 360 Stroke solution for AI-powered stroke imaging.
Brainomix announced today that it received FDA clearance for a new feature within its 360 Stroke solution for AI-powered stroke imaging.
Proprio announced today that it received its second FDA 510(k) clearance for its Paradigm AI guidance platform for surgery.
CardioVia announced today that it received FDA clearance for its minimally invasive ViaOne epicardial access system.
Advanced Dosimetry Software Expands Capabilities for Personalized Radiopharmaceutical Therapies
Breakthrough Innovation Promises Superior Sensitivity and Precision in Radiation Detection Technologies
Insulet (Nasdaq:PODD) announced today that it commercially launched the Omnipod 5 automated insulin delivery (AID) system in Canada.
ICU Medical (Nasdaq: ICUI) announced today that it received FDA 510(k) clearance for several new additions to its infusion pump portfolio.
Satio announced today that it completed a Small Business Innovation Research (SBIR) contract for its intradermal drug delivery system.
New research on a cytokine called IL-17 adds to growing evidence that immune molecules can influence behavior during illness.
Provider groups and health systems warn tariffs will test healthcare’s fragile supply chain, and Wall Street said medtech businesses will face pressure, particularly diabetes tech firms.